Combined Targeted Therapies for First‐line Treatment of Metastatic Triple Negative Breast Cancer—A Phase II Trial of Weekly Nab‐Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.12.008
The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.04.007
Beliefs About Medication and Uptake of Preventive Therapy in Women at Increased Risk of Breast Cancer: Results From a Multicenter Prospective Study
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.10.008
Dietary Habits and Physical Activity are Associated With the Risk of Breast Cancer Among Young Iranian Women: A Case‐control Study on 1010 Premenopausal Women
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.10.011
Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.01.007
Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.04.004
Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.06.007
Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.05.007
Radical Mastectomy Increases Psychological Distress in Young Breast Cancer Patients: Results of A Cross‐sectional Study
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.08.013
Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.01.014
Characteristics and Outcomes of BI‐RADS 3 Lesions on Breast MRI
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.08.011
Phase II, Multicenter, Single‐arm Trial of Eribulin as First‐line Therapy for Patients With Aggressive Taxane‐pretreated HER2‐Negative Metastatic Breast Cancer: The MERIBEL Study
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.12.012
Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.11.010
MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.08.010
A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.06.005
Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.05.020
The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.07.007
Individualized Prediction of Menses Recovery After Chemotherapy for Early‐stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.08.005
Implementing a Population-Based Breast Cancer Risk Assessment Program.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.02.009
Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14).
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.09.004
Meta‐analysis of the Correlation Between Schizophrenia and Breast Cancer
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.10.012
Extended Adjuvant Therapy With Aromatase Inhibitors for Early Breast Cancer: A Meta-analysis of Randomized Controlled Trials.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.03.005
Impact of 21‐Gene Expression Assay on Staging Estrogen Receptor–Positive HER2‐Negative Breast Cancer
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.10.005
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.05.006
Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.02.010
Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG‐PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.11.010
Timeliness of Treatment Initiation in Newly Diagnosed Patients With Breast Cancer.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.06.009
Screening Mammography Findings in Women With Chronic Kidney Disease on a Renal Transplant Waiting List.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.01.009
The Undervalued Effects of Polychlorinated Biphenyl Exposure on Breast Cancer.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.07.005
Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.01.003
Implementation of a Multidisciplinary Model of Care for Women With Metastatic Breast Cancer: Challenges and Lessons Learned
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.12.014
Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.07.001
Mammography Coverage and Tumor Stage in the Opportunistic Screening Context.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.04.014
Oncoplastic Breast Surgery Compared to Conventional Breast-Conserving Surgery With Regard to Oncologic Outcome.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.05.016
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.06.008
Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 Chinese Representative Clinical Centers.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.07.013
Long-Term Follow-up of Immediate Latissimus Dorsi Flap Reconstruction After Neoadjuvant Chemotherapy and Radiotherapy for Invasive Breast Cancer.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.03.007
Comparison of Radio-guided Occult Lesion Localization (ROLL) and Magnetic Occult Lesion Localization (MOLL) for Non-palpable Lesions: A Phantom Model Study.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.09.002
Isolated Tumor Cells in Sentinel Lymph Nodes of Primary Invasive Breast Carcinoma: A Cohort Analysis.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.03.002
Implant-sparing Mastectomy: An Alternative for Women Undergoing Mastectomy With Retropectoral Implants.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.08.007
Effectiveness of Adjuvant Ovarian Function Suppression in Premenopausal Women With Early Breast Cancer: A Multicenter Cohort Study.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.06.003
Prophylactic Versus Therapeutic Mastectomy: A Contemporary Analysis of the ACS-NSQIP Database.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.01.008
The Impact of a Postmastectomy Chest Wall Scar Boost on Local Recurrence-free Survival in High-risk Patients.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.04.010
Development of Phase-Specific Breast Cancer Survivorship Care Plans.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.05.017
New Cardiac Abnormalities After Radiotherapy in Breast Cancer Patients Treated With Trastuzumab.
来源期刊:Clinical breast cancerDOI:10.1016/j.clbc.2019.12.006
Radiotherapy After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.04.002
Longer Times of Receipt of Adjuvant Endocrine Therapy Correspond to Improved Functional Capacity and Lower Adiposity in Women Receiving Adjuvant Therapy
来源期刊:Clinical Breast CancerDOI:10.1016/j.clbc.2018.09.003
Our Radiological Experience on B3 Lesions: Correlation Between Mammographic and MRI Findings With Histologic Definitive Result.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.06.004
LOC643714 Polymorphisms Contribute to an Elevated Susceptibility to Breast Cancer: A Meta-analysis of 231,191 Subjects.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.04.016
Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy.
来源期刊:Clinical breast cancerDOI:10.1016/J.CLBC.2019.05.002